Indication
Opioid use disorder
Opioid use disorder is a chronic, relapsing neurobehavioral condition characterized by a problematic pattern of opioid use that leads to clinically significant impairment or distress. Read more about Opioid use disorder
112 drugs 59 manufacturers
Drugs that treat it
Common Opioid use disorder therapies.
SUBOXONE (buprenorphine HCl/naloxone HCl)
METHADONE HCL
METHADONE HCL
METHADONE (methadone HCl)
METHADONE HCL
BUPRENORPHINE HCL
METHADOSE (methadone HCl)
METHADONE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOpioid use disorder is a chronic, relapsing neurobehavioral condition characterized by a problematic pattern of opioid use that leads to clinically significant impairment or distress.
Primarily affecting the central nervous system's mesolimbic reward and stress circuits, it can develop in individuals exposed to prescribed analgesics or illicit opioids.
Defining pathophysiologic and clinical features include intense opioid craving, loss of control over consumption, persistent use despite adverse health or social consequences, and neuroadaptations that frequently produce tolerance and physical withdrawal upon cessation.
- psychiatry.org
Opioid use disorder is a chronic, relapsing neurobehavioral condition characterized by a problematic pattern of opioid use that leads to clinically significant impairment or distress Defining pathophysiologic and clinical features include intense opioid craving, loss of control over consumption, persistent use despite adverse health or social consequences, and neuroadaptations that frequently produce tolerance and physical withdrawal upon cessation
- theravive.com
Opioid use disorder is a chronic, relapsing neurobehavioral condition characterized by a problematic pattern of opioid use that leads to clinically significant impairment or distress Primarily affecting the central nervous system's mesolimbic reward and stress circuits, it can develop in individuals exposed to prescribed analgesics or illicit opioids
- cdc.gov
Primarily affecting the central nervous system's mesolimbic reward and stress circuits, it can develop in individuals exposed to prescribed analgesics or illicit opioids
- asam.org
Defining pathophysiologic and clinical features include intense opioid craving, loss of control over consumption, persistent use despite adverse health or social consequences, and neuroadaptations that frequently produce tolerance and physical withdrawal upon cessation
- honeylake.clinic
Defining pathophysiologic and clinical features include intense opioid craving, loss of control over consumption, persistent use despite adverse health or social consequences, and neuroadaptations that frequently produce tolerance and physical withdrawal upon cessation
Personalize your experience
Follow Opioid use disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.